• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR Back to Search Results
Model Number PLASMAFLO OP
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Complaint, Ill-Defined (2331)
Event Date 06/02/2015
Event Type  Injury  
Event Description
A hospitalized male patient experienced the following adverse event in (b)(6).(b)(6) 2015 the patient's blood pressure was 139/72 mmhg when he entered the treatment room.10:55 treatment of immunoadsorption plasmapheresis(iapp) with plasmaflo op started for the patient.The treatment condition was as follows; blood flow rate: 100ml/min., plasma flow rate:30ml/min.11:50 the patient's blood pressure decreased to 69/50 mmhg, so the treatment of iapp was stopped, and the blood was returned to the patient.Four minutes after the patient's blood returned, a half ampule of atropine injection was given.After two minutes, the patient did not recovered, so the patient was treated with rest half of atropine injection and then with veen-f inj.Intravenously.Nine minutes after the patient's blood returned, the patient's blood pressure recovered to 98/66 mmhg, while the patient's dysphoria remained.(b)(6) 2015 improvement of the patient's condition was confirmed.
 
Manufacturer Narrative
The product in complaint was not returned to the manufacturer and could not be analyzed.The lot number in complaint was not reported and we could not review the manufacturing and quality control records.Hypotension is listed in ifu as the event to monitor during the treatment.This ae might occurred in part or in total related to the patient's physiology.Plasmaflo op is used as plasma separator and immusorba tr is used for immunoadsorption colimn for separated plasma.This incident occurred in (b)(6) and is reported to fda according to the requirement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-105, kanda,
jinbocho, chiyoda-ku,
tokyo, 101-8 101
JA  101-8101
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
2111-2 oaza sato,
oita, oita 870- 0396
JA   870-0396
Manufacturer Contact
kaoru furuya
1-105, kanda jinbocho,
chiyoda-ku,
tokyo, 101-8-101
JA   101-8101
MDR Report Key4880732
MDR Text Key18295924
Report Number8010002-2015-00010
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 06/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPLASMAFLO OP
Device Catalogue NumberOP-05W
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/02/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
IMMUSORBA-TR350
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age55 YR
Patient Weight90
-
-